Swiss National Bank lifted its holdings in HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 1.1% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 171,700 shares of the company’s stock after purchasing an additional 1,800 shares during the period. Swiss National Bank owned approximately 0.20% of HealthEquity worth $16,475,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in the business. Avantax Advisory Services Inc. grew its holdings in shares of HealthEquity by 23.4% in the fourth quarter. Avantax Advisory Services Inc. now owns 9,645 shares of the company’s stock valued at $925,000 after purchasing an additional 1,827 shares in the last quarter. Sequoia Financial Advisors LLC grew its holdings in shares of HealthEquity by 7.9% in the fourth quarter. Sequoia Financial Advisors LLC now owns 14,364 shares of the company’s stock valued at $1,378,000 after purchasing an additional 1,050 shares in the last quarter. HighTower Advisors LLC grew its holdings in shares of HealthEquity by 4.8% in the fourth quarter. HighTower Advisors LLC now owns 95,075 shares of the company’s stock valued at $9,122,000 after purchasing an additional 4,370 shares in the last quarter. AGF Management Ltd. grew its holdings in shares of HealthEquity by 3.7% in the fourth quarter. AGF Management Ltd. now owns 135,857 shares of the company’s stock valued at $13,035,000 after purchasing an additional 4,819 shares in the last quarter. Finally, Wealthfront Advisers LLC acquired a new position in shares of HealthEquity in the fourth quarter valued at approximately $10,304,089,000. Institutional investors and hedge funds own 99.55% of the company’s stock.
Insider Activity at HealthEquity
In related news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares in the company, valued at $8,704,992.51. This represents a 6.85 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 2.20% of the stock is owned by insiders.
Analyst Ratings Changes
Get Our Latest Analysis on HQY
HealthEquity Trading Up 0.9 %
Shares of HealthEquity stock opened at $101.67 on Wednesday. The company has a fifty day simple moving average of $105.82 and a 200-day simple moving average of $95.67. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $115.59. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The stock has a market cap of $8.81 billion, a price-to-earnings ratio of 93.28, a PEG ratio of 1.60 and a beta of 0.62.
HealthEquity Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
See Also
- Five stocks we like better than HealthEquity
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Russell 2000 Index, How Investors Use it For Profitable Trading
- 3 Must-Own Stocks to Build Wealth This Decade
- 10 Best Airline Stocks to Buy
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.